Medibio Limited [ASX:MEB] share price and news 2022

Company Description

Medibio Limited (MEB, formerly BioProspect Limited) is a medical technology company that conducts clinical research, product development and early stage commercialization of a mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions.

Medibio Limited belongs to Health Care sector and under industry of Health Care Technology. You can get more information about this company via their website: http://www.medibio.com.au.

This a small cap company with market cap of 14 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is less than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 0.78 0
Market 0.85 22.3 1.99 0.84
Sector 1.29 25.9 4.23 1.53

Dividend Growth Chart

The following chart shows you how meb dividend grows in the recent years.

No data